Millennium Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9M | Buy |
1,104,839
+691,410
| +167% | +$22.5M | 0.02% | 742 |
|
|
2025
Q1 | $15.6M | Buy |
413,429
+136,851
| +49% | +$5.17M | 0.01% | 1235 |
|
|
2024
Q4 | $22.6M | Sell |
276,578
-21,857
| -7% | -$1.79M | 0.01% | 1025 |
|
|
2024
Q3 | $34.1M | Buy |
298,435
+94,704
| +46% | +$10.8M | 0.02% | 780 |
|
|
2024
Q2 | $15.4M | Sell |
203,731
-3,251
| -2% | -$245K | 0.01% | 1217 |
|
|
2024
Q1 | $14.1M | Sell |
206,982
-484,450
| -70% | -$33.1M | 0.01% | 1267 |
|
|
2023
Q4 | $43.4M | Buy |
691,432
+108,563
| +19% | +$6.82M | 0.02% | 573 |
|
|
2023
Q3 | $29.7M | Sell |
582,869
-631,203
| -52% | -$32.2M | 0.02% | 738 |
|
|
2023
Q2 | $60.6M | Sell |
1,214,072
-99,570
| -8% | -$4.97M | 0.03% | 417 |
|
|
2023
Q1 | $49.2M | Buy |
1,313,642
+94,151
| +8% | +$3.53M | 0.03% | 487 |
|
|
2022
Q4 | $58.5M | Buy |
1,219,491
+433,169
| +55% | +$20.8M | 0.03% | 422 |
|
|
2022
Q3 | $18.9M | Buy |
786,322
+220,206
| +39% | +$5.29M | 0.01% | 962 |
|
|
2022
Q2 | $12.3M | Buy |
566,116
+303,396
| +115% | +$6.6M | 0.01% | 1304 |
|
|
2022
Q1 | $6.35M | Sell |
262,720
-23,603
| -8% | -$570K | ﹤0.01% | 2062 |
|
|
2021
Q4 | $6.81M | Buy |
286,323
+5,039
| +2% | +$120K | ﹤0.01% | 1958 |
|
|
2021
Q3 | $7.14M | Sell |
281,284
-34,329
| -11% | -$871K | ﹤0.01% | 1843 |
|
|
2021
Q2 | $7.1M | Sell |
315,613
-37,841
| -11% | -$852K | ﹤0.01% | 1758 |
|
|
2021
Q1 | $6.98M | Sell |
353,454
-72,370
| -17% | -$1.43M | 0.01% | 1741 |
|
|
2020
Q4 | $11.3M | Buy |
425,824
+330,164
| +345% | +$8.77M | 0.01% | 1222 |
|
|
2020
Q3 | $4.72K | Sell |
95,660
-772,658
| -89% | -$38.2K | 0.01% | 1469 |
|
|
2020
Q2 | $27.4M | Buy |
+868,318
| New | +$27.4M | 0.04% | 406 |
|